Compare Gigacloud Technology Inc (GCT) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Gigacloud Technology Inc trades at $56.52 (market cap $2.00B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Gigacloud Technology Inc and SELLAS Life Sciences Group Inc. Common Stock are close in size by market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| GCT | SLS | |
|---|---|---|
Market Cap | $2.00B | $2.28B |
Volume | 1,000,927 | 3,128,960 |
Sector | Technology | Health |
52-Week High | $56.42 | $15.46 |
52-Week Low | $25.46 | $1.39 |
Typical Hold Time | 21 Days | — |
Enterprise Value | $2.13B | $2.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $55.96, up 2.19% today, with a bullish technical signal from moving averages and strong fundamental performance. The company reported Q2 2026 EPS of $1.16, beating estimates of $0.90, continuing a trend of earnings beats. Revenue grew to $1.29 billion in 2025, with net income of $137.37 million and a healthy net margin of 10.65%. The stock is supported by positive cash flow from operations of $190.66 million in 2025.
The outlook for GCT is positive, driven by consistent earnings outperformance and robust profitability metrics like a 32.34% ROE. Risks include potential overbought conditions with an RSI of 72.38 and insider selling activity. Analyst consensus is bullish with a $32.50 price target, though the current price exceeds this, suggesting cautious optimism amid growth execution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
